KPV
KPV Product Description — Research Use Only
KPV is a research tripeptide made from the amino acids lysine, proline, and valine. It is the C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone, also known as alpha-MSH, and is commonly studied for inflammation-response pathways, immune signaling, gut-barrier research, skin-cell activity, antimicrobial activity, and wound-healing models.
Research on KPV has most commonly focused on inflammation response, immune regulation, intestinal barrier pathways, skin inflammation research, antimicrobial defense, wound-repair signaling, and cellular stress response. Published research describes KPV as a minimal alpha-MSH-derived sequence that retains anti-inflammatory activity while lacking the broader pigmentary activity associated with full alpha-MSH.
KPV is commonly studied for:
Inflammation response — how cells regulate stress-related inflammatory signals
Immune signaling — how immune pathways respond to irritation, stress, or imbalance
Gut-barrier research — how intestinal lining pathways are protected and regulated
Skin-cell research — how skin cells respond to inflammation-related signals
Antimicrobial activity — how alpha-MSH-related peptides interact with microbial defense pathways
Wound-healing research — how tissue repair and recovery signals are activated
Cell protection — how cells respond to stress and maintain normal function
KPV is commonly studied because it represents one of the smallest alpha-MSH-derived peptide fragments associated with anti-inflammatory activity. Research has explored its role in intestinal inflammation models, keratinocyte signaling, antimicrobial effects against organisms such as Staphylococcus aureus and Candida albicans, and broader immune-mediated inflammation pathways.
For research use only. Not for human consumption, medical use, diagnostic use, or therapeutic application.
